Mass General Brigham, Inc Portfolio Holdings

Mass General Brigham, Inc has filed its 13F form on October 16, 2024 for Q3 2024 where it was disclosed a total value porftolio of $43.6 Billion distributed in 50 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Samsara Inc. with a value of $21.6B, Revolution Medicines, Inc. with a value of $15.3B, Pliant Therapeutics, Inc. with a value of $3.24B, Tango Therapeutics, Inc. with a value of $2.73B, and Fulcrum Therapeutics, Inc. with a value of $733M.

Examining the 13F form we can see an increase of $23.1B in the current position value, from $20.5B to 43.6B.

Below you can find more details about Mass General Brigham, Inc portfolio as well as his latest detailed transactions.